The role of NKD2 and its inhibitory impact on the WNT signaling pathway has previously been documented in the context of suppressing tumor growth and metastasis in osteosarcoma [34], colorectal carcinoma [53], and acute myeloid leukemia [54]. This evidence concerns the gene NKD2 and acute myeloid leukemia.